Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jin Dun Medical Research Institute
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Jin Dun Medical Research Institute supplies pharmaceutical intermediates and APIs for a broad range of indications, with expertise in custom synthesis and GMP-grade production; no evidence of its own clinical results or proprietary drugs.
- Therapeutic areas
- EndocrinologyPsychiatryInfectious DiseasesHematologyCardiovascularOncologyNeurology
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
Chinese academic institutions/universitiesBeijing University of Chemical TechnologyDonghua UniversityZhejiang UniversityShanghai Institute of Organic Chemistry
Beyond the preview
Go deeper on Jin Dun Medical Research Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jin Dun Medical Research Institute.